Brussels: The European Commission has approved a supply contract with the company A.S.
Novavaks for purchases of up to 200 million Covid-19 vaccines, the European Commission said on Wednesday.
Under the contract, the EU countries will be able to buy up to 100 million doses of Novavax vaccine, with options for 100 million additional doses of up to 2023, after shooting has been approved by the EU drug regulator, the Commission said.
The EU seal deals with Novavaks to 200 million Covid-19 vaccine
